Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Mortgage Loans (2018 - 2020)

CollPlant Biotechnologies filings provide 3 years of Mortgage Loans readings, the most recent being $6000.0 for Q3 2020.

  • On a quarterly basis, Mortgage Loans fell 66.67% to $6000.0 in Q3 2020 year-over-year; TTM through Sep 2020 was $6000.0, a 66.67% decrease, with the full-year FY2019 number at $24000.0, up 9.09% from a year prior.
  • Mortgage Loans hit $6000.0 in Q3 2020 for CollPlant Biotechnologies, down from $12000.0 in the prior quarter.
  • In the past five years, Mortgage Loans ranged from a high of $58000.0 in Q2 2018 to a low of $6000.0 in Q3 2020.
  • Median Mortgage Loans over the past 3 years was $20000.0 (2018), compared with a mean of $22800.0.
  • The widest YoY moves for Mortgage Loans: up 9.09% in 2019, down 68.97% in 2019.
  • CollPlant Biotechnologies' Mortgage Loans stood at $22000.0 in 2018, then grew by 9.09% to $24000.0 in 2019, then crashed by 75.0% to $6000.0 in 2020.
  • The last three reported values for Mortgage Loans were $6000.0 (Q3 2020), $12000.0 (Q2 2020), and $18000.0 (Q1 2020) per Business Quant data.